You are here

Medicinal cannabis

Most medicinal cannabis products are unapproved therapeutic goods, which means they have not been assessed by the TGA for safety, quality or effectiveness. However, where clinically appropriate, there are pathways for doctors to access medicinal cannabis products for their patients.

Information on the TGA’s role in providing access pathways to medicinal cannabis, including approval statistics, quality standard measures and scheduling

Find out how the TGA provides safe and legal access to medicinal cannabis products in appropriate circumstances

Clinical guidance and information about access pathways for medicinal cannabis products

Information for sponsors and manufacturers about product quality and manufacturing standards for medicinal cannabis products

Read the latest news and updates related to medicinal cannabis